Literature DB >> 30373855

Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.

Samuel W Du1, Holly M Jacobs1, Tanvi Arkatkar1, David J Rawlings2,3,4, Shaun W Jackson2,4.   

Abstract

The B cell survival cytokine BAFF has been linked with the pathogenesis of systemic lupus erythematosus (SLE). BAFF binds distinct BAFF-family surface receptors, including the BAFF-R and transmembrane activator and CAML interactor (TACI). Although originally characterized as a negative regulator of B cell activation, TACI signals are critical for class-switched autoantibody (autoAb) production in BAFF transgenic mice. Consistent with this finding, a subset of transitional splenic B cells upregulate surface TACI expression and contribute to BAFF-driven autoAb. In the current study, we interrogated the B cell signals required for transitional B cell TACI expression and Ab production. Surprisingly, despite established roles for dual BCR and TLR signals in autoAb production in SLE, signals downstream of these receptors exerted distinct impacts on transitional B cell TACI expression and autoAb titers. Whereas loss of BCR signals prevented transitional B cell TACI expression and resulted in loss of serum autoAb across all Ig isotypes, lack of TLR signals exerted a more limited impact restricted to autoAb class-switch recombination without altering transitional B cell TACI expression. Finally, in parallel with the protective effect of TACI deletion, loss of BAFF-R signaling also protected against BAFF-driven autoimmunity. Together, these findings highlight how multiple signaling pathways integrate to promote class-switched autoAb production by transitional B cells, events that likely impact the pathogenesis of SLE and other BAFF-dependent autoimmune diseases.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30373855      PMCID: PMC6779322          DOI: 10.4049/jimmunol.1800393

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization.

Authors:  W Yu; H Nagaoka; M Jankovic; Z Misulovin; H Suh; A Rolink; F Melchers; E Meffre; M C Nussenzweig
Journal:  Nature       Date:  1999-08-12       Impact factor: 49.962

2.  T-bet regulates T-independent IgG2a class switching.

Authors:  Andrea J Gerth; Ling Lin; Stanford L Peng
Journal:  Int Immunol       Date:  2003-08       Impact factor: 4.823

Review 3.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

4.  Differential induction of plasma cells by isoforms of human TACI.

Authors:  Yolanda Garcia-Carmona; Montserrat Cols; Adrian T Ting; Lin Radigan; Frank J Yuk; Li Zhang; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

5.  The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.

Authors:  William A Figgett; Kirsten Fairfax; Fabien B Vincent; Mélanie A Le Page; Indzi Katik; Devy Deliyanti; Pin Shie Quah; Pali Verma; Raelene Grumont; Steve Gerondakis; Paul Hertzog; Lorraine A O'Reilly; Andreas Strasser; Fabienne Mackay
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

6.  Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.

Authors:  C C Goodnow; J Crosbie; S Adelstein; T B Lavoie; S J Smith-Gill; R A Brink; H Pritchard-Briscoe; J S Wotherspoon; R H Loblay; K Raphael
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

7.  BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling.

Authors:  Sarah L Rowland; Katelyn F Leahy; Regina Halverson; Raul M Torres; Roberta Pelanda
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

8.  Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation.

Authors:  Shaun W Jackson; Nicole E Scharping; Nikita S Kolhatkar; Socheath Khim; Marc A Schwartz; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; Denny Liggitt; David J Rawlings
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

9.  Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.

Authors:  William A Figgett; Devy Deliyanti; Kirsten A Fairfax; Pin Shie Quah; Jennifer L Wilkinson-Berka; Fabienne Mackay
Journal:  J Autoimmun       Date:  2015-05-29       Impact factor: 7.094

10.  Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.

Authors:  M A Dooley; F Houssiau; C Aranow; D P D'Cruz; A Askanase; D A Roth; Z J Zhong; S Cooper; W W Freimuth; E M Ginzler
Journal:  Lupus       Date:  2013-01       Impact factor: 2.911

View more
  7 in total

Review 1.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

Review 2.  The Plasticity of Newly Formed B Cells.

Authors:  Natalia V Giltiay; Daniela Giordano; Edward A Clark
Journal:  J Immunol       Date:  2019-12-15       Impact factor: 5.422

Review 3.  TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals.

Authors:  Anne B Satterthwaite
Journal:  Curr Rheumatol Rep       Date:  2021-11-24       Impact factor: 4.592

4.  Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector.

Authors:  Brenda J Seymour; Swati Singh; Hannah M Certo; Karen Sommer; Blythe D Sather; Socheath Khim; Courtnee Clough; Malika Hale; Joseph Pangallo; Byoung Y Ryu; Iram F Khan; Jennifer E Adair; David J Rawlings
Journal:  Mol Ther Methods Clin Dev       Date:  2021-01-20       Impact factor: 6.698

Review 5.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04

6.  TACI haploinsufficiency protects against BAFF-driven humoral autoimmunity in mice.

Authors:  Holly M Jacobs; Tanvi Arkatkar; Samuel W Du; Nicole E Scharping; Jonathan Woods; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; David J Rawlings; Shaun W Jackson
Journal:  Eur J Immunol       Date:  2021-06-27       Impact factor: 6.688

Review 7.  B Cells in Systemic Lupus Erythematosus: From Disease Mechanisms to Targeted Therapies.

Authors:  Susan P Canny; Shaun W Jackson
Journal:  Rheum Dis Clin North Am       Date:  2021-06-16       Impact factor: 2.032

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.